EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:194124 - akebia saponin D
| Formula | C47H76O18 |
| Net Charge | 0 |
| Average Mass | 929.107 |
| Monoisotopic Mass | 928.50317 |
| SMILES | [H][C@]12CC=C3[C@]4([H])CC(C)(C)CC[C@]4(C(=O)O[C@@H]4O[C@H](CO[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)CC[C@@]3(C)[C@]1(C)CC[C@]1([H])[C@]2(C)CC[C@H](O[C@@H]2OC[C@H](O)[C@H](O)[C@H]2O)[C@@]1(C)CO |
| InChI | InChI=1S/C47H76O18/c1-42(2)13-15-47(41(59)65-40-37(58)34(55)32(53)26(63-40)20-61-38-36(57)33(54)31(52)25(18-48)62-38)16-14-45(5)22(23(47)17-42)7-8-28-43(3)11-10-29(64-39-35(56)30(51)24(50)19-60-39)44(4,21-49)27(43)9-12-46(28,45)6/h7,23-40,48-58H,8-21H2,1-6H3/t23-,24-,25+,26+,27+,28+,29-,30-,31+,32+,33-,34-,35+,36+,37+,38+,39-,40-,43-,44-,45+,46+,47-/m0/s1 |
| InChIKey | CCRXMHCQWYVXTE-HMRSNRLKSA-N |
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Dipsacus asper (ncbitaxon:516548) | Root (BTO:0001188) | PubMed (19023535) | |
| Stauntonia hexaphylla (ncbitaxon:41788) | |||
| leaf (BTO:0000713) | PubMed (30808589) | ||
| fruit (BTO:0000486) | PubMed (31301930) |
| Roles Classification |
|---|
| Biological Roles: | apoptosis inducer Any substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms. plant metabolite Any eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms. metabolite Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. |
| Applications: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. neuroprotective agent Any compound that can be used for the treatment of neurodegenerative disorders. anti-inflammatory agent Any compound that has anti-inflammatory effects. bone density conservation agent An agent that inhibits bone resorption and/or favor bone mineralization and bone regeneration. Used to heal bone fractures and to treat bone diseases such as osteopenia and osteoporosis. antilipemic drug A substance used to treat hyperlipidemia (an excess of lipids in the blood). |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| akebia saponin D (CHEBI:194124) has functional parent hederagenin (CHEBI:69579) |
| akebia saponin D (CHEBI:194124) has role anti-inflammatory agent (CHEBI:67079) |
| akebia saponin D (CHEBI:194124) has role antilipemic drug (CHEBI:35679) |
| akebia saponin D (CHEBI:194124) has role antineoplastic agent (CHEBI:35610) |
| akebia saponin D (CHEBI:194124) has role apoptosis inducer (CHEBI:68495) |
| akebia saponin D (CHEBI:194124) has role bone density conservation agent (CHEBI:50646) |
| akebia saponin D (CHEBI:194124) has role neuroprotective agent (CHEBI:63726) |
| akebia saponin D (CHEBI:194124) has role plant metabolite (CHEBI:76924) |
| akebia saponin D (CHEBI:194124) is a carboxylic ester (CHEBI:33308) |
| akebia saponin D (CHEBI:194124) is a pentacyclic triterpenoid (CHEBI:25872) |
| akebia saponin D (CHEBI:194124) is a trisaccharide derivative (CHEBI:63571) |
| akebia saponin D (CHEBI:194124) is a triterpenoid saponin (CHEBI:61778) |
| IUPAC Name |
|---|
| 1-O-[3β-(α-L-arabinopyranosyloxy)-23-hydroxy-28-oxoolean-12-en-28-yl]-6-O-β-D-glucopyranosyl-β-D-glucopyranose |
| Synonyms | Source |
|---|---|
| hederagenin 3-O-α-L-arabinopyranosyl-28-β-D-glucopyranosyl(1→6)-β-D-glucopyranoside | ChEBI |
| tauroside St-G0-1 | ChEBI |
| asperosaponin VI | ChEBI |
| leiyemudanoside A | ChEBI |
| ASA VI | ChEBI |
| asperosaponin VI | ChEBI |
| Registry Numbers | Sources |
|---|---|
| CAS:39524-08-8 | ChemIDplus |
| Citations |
|---|